Search for: "Bristol Myers Squibb Manufacturing Company" Results 121 - 140 of 161
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
20 Mar 2023, 7:52 am by Rebecca Tushnet
Bristol-Myers Squibb Co., 2023 WL 2519857, SCAP-21-0000363, --- P.3d ---- (Hawai’i Mar. 15, 2023) The state sued two pharmaceutical companies for violating Hawai‘i’s Unfair or Deceptive Acts or Practices law (UDAP) by misleading the public about the safety and efficacy of their antiplatelet drug, Plavix. [read post]
4 Oct 2023, 10:00 pm by Kurt R. Karst
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch)… [read post]
15 Oct 2008, 3:02 pm
Much of the lobbying efforts were aimed at Sheldon Bradshaw, who had succeeded Daniel Troy as FDA chief counsel in April 2005.AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas,… [read post]
14 Dec 2017, 10:48 pm by GJEL
The remaining manufacturers, including Bristol-Myers Squibb, ultimately settled for $3.4 billion, and Dow Corning resolved its claims in bankruptcy court. [read post]
5 Mar 2024, 11:47 am by Kurt R. Karst
PLAINTIFF COURT AND DATE OF COMPLAINT SELECTED DRUGS (FOR YEAR 2026) Bristol Myers Squibb D.N.J. (16 June 2023) Eliquis Novartis D.N.J. (1 Sept. 2023) Entresto J&J’s Janssen Pharms. [read post]
6 Jan 2023, 2:33 pm by anne
Bristol-Myers Squibb paying $75 million to resolve allegations was the seventh largest Healthcare Fraud recovery on last year’s list. [read post]
26 Oct 2022, 3:17 am by Cari Rincker
(Nov. 24, 2021), https://ag.ny.gov/press-release/2021/attorney-general-james-secures-51-million-judgment-against-new-york-city-stem. [5] $834 Million Order Entered in Hawai‘i State Court against Bristol-Myers Squibb and Sanofi for Failing to Investigate and Disclose Ineffectiveness of Plavix®, Dept. of the Att’y Gen. [read post]
18 Jul 2014, 11:55 am
We are unwilling to make brand manufacturers the de facto insurers for competing generic manufacturers. [read post]
29 Jul 2009, 6:45 am
(Patent Circle) India: ‘In transit’ drug seizures and TRIPS: UK decision may help Indian companies (Spicy IP) India: Public interest litigation to prevent GM seeds in India (IP Osgoode) Isle of Man: SPCs on the Isle of Man (The SPC Blog) US: Board decision in Ex Parte Roberts doesn’t make the cut (Patents4Life) US: Are you getting all the patent term you should? [read post]
9 Oct 2020, 9:57 am by Howard M. Wasserman
The case is controlled by the court’s 2017 decision in Bristol-Myers Squibb v. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
  Courts do not require companies to be pessimistic in assessing arguably negative results; they merely require that companies be honest in their statements and forthcoming with the relevant underlying facts. [read post]
10 Oct 2016, 2:59 pm by Michael Grossman
Made by Bristol-Myers Squibb, Taxol is also used as a component of intravenous chemotherapy. [read post]
15 May 2014, 11:40 am
I accept that, for the reasons explained by Jacob J in Bristol-Myers Squibb and Lord Hoffmann in Kirin-Amgen, courts should be cautious before relying upon prosecution history as an aid to construction. [read post]
26 Feb 2015, 5:00 am
  In Henderson, the plaintiff failed to prove negligence but claimed that “‘even if the Drug Company was not negligent . [read post]
20 May 2012, 1:11 pm
  The number 50 million:  The number of people in the US since 1997, that have taken Bristol-Myers Squibb's blood-thinning drug Plavix. [read post]